Moxifloxacin induced encephalopathy in disseminated tuberculosis: A case report

2001 Ball, 1999, Comparative tolerability of the newer fluoroquinolone antibacterials, Drug Saf, 21, 407, 10.2165/00002018-199921050-00005 Ginsburg, 2003, Fluoroquinolones, tuberculosis, and resistance, Lancet Infect Dis, 3, 432, 10.1016/S1473-3099(03)00671-6 Caminero, 2010, Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis, Lancet Infect Dis, 10, 621, 10.1016/S1473-3099(10)70139-0 Bowie, 1989, Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin, Antimicrob Agents Chemother, 33, 1778, 10.1128/AAC.33.10.1778 Barrett, 2009, Gemifloxacin-associated neurotoxicity presenting as encephalopathy, Ann Pharmacother, 43, 782, 10.1345/aph.1L621 Slobodin, 2009, Levofloxacin induced delirium, Neurol Sci, 30, 159, 10.1007/s10072-009-0027-9 Tomé, 2011, Quinolones: review of psychiatric and neurological adverse reactions, Drug Saf, 34, 465, 10.2165/11587280-000000000-00000 Schmuck, 1998, Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model, Antimicrob Agents Chemother (Bethesda), 42, 1831, 10.1128/AAC.42.7.1831 Akahane, 1994, Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding, Chemotherapy, 40, 412, 10.1159/000239301